Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 25, 2021 - Issue 10
Submit an article Journal homepage
271
Views
6
CrossRef citations to date
0
Altmetric
Review

A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)

Stuart K RobertsDepartment of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, AustraliaCorrespondence[email protected]
View further author information
&
Ammar MajeedDepartment of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, AustraliaView further author information
Pages 889-895 | Received 10 Jul 2021, Accepted 25 Oct 2021, Published online: 18 Nov 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tobias Puengel & Frank Tacke. (2023) Efruxifermin, an investigational treatment for fibrotic or cirrhotic nonalcoholic steatohepatitis (NASH). Expert Opinion on Investigational Drugs 32:6, pages 451-461.
Read now

Articles from other publishers (5)

Lijun Luo, Yongchun Chang & Li Sheng. (2023) Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective. Life Sciences 321, pages 121614.
Crossref
Haoyu Tian, Shuairan Zhang, Ying Liu, Yifan Wu & Dianbao Zhang. (2023) Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges. International Journal of Molecular Sciences 24:5, pages 4583.
Crossref
Tianru Jin. (2022) Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next. Medical Review 2:5, pages 524-530.
Crossref
Tieshan Teng, Shuai Qiu, Yiming Zhao, Siyuan Zhao, Dequan Sun, Lingzhu Hou, Yihang Li, Ke Zhou, Xixi Yu, Changyong Yang & Yanzhang Li. (2022) Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 23:14, pages 7841.
Crossref
Takeshi Katafuchi & Makoto Makishima. (2022) Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis. International Journal of Molecular Sciences 23:11, pages 6046.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.